+ All Categories
Home > Technology > Biocroi web presentation 07 03-2012

Biocroi web presentation 07 03-2012

Date post: 11-Nov-2014
Category:
Upload: biocroi
View: 551 times
Download: 2 times
Share this document with a friend
Description:
The latest concept in microplate design involving a gel base technology. The full functionality of conventional microplates with environmental buffering technology on-board reducing edge-effects and permitting extreme miniaturisation all in existing SBS format
Popular Tags:
29
Biocroí Ltd. Unit 3, 80 The Trinity Centre St James’s Hospital, Dublin 8, Ireland March 2012 CONFIDENTIALITY NOTICE This document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company. Gel Base Bioreactor Technology At the cutting edge of cell based assays
Transcript
Page 1: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

March 2012

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

Gel Base Bioreactor Technology

At the cutting edge of cell based assays

Page 2: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

The problem

Page 3: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

All chemical and biological processes are influenced by environmental elements such as temperature, pH and chemical composition.

Page 4: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

CellBasedAssays

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

Environmental Concerns

Mechanical disturbances (Vibrations etc)

Alterations in water media hydration

Variations in dissolved CO2

Fluctuations in thermal conditions

Page 5: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

Uncontrolled changes in any of these factors can exert unwanted physical, chemical and/or biological effects on the specimen/sample in question leading to poor reproducibility or disruption of a given scientific and/or manufacturing process

Page 6: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

Disruption &

Poor Reproducibility

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

Negative outcomes

Increased Heterogeneity in cell populations

Cellular stress

Aberrant gene expression

Retardation of growth

Page 7: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

With the emergence of high throughput and multiplexed biological, chemical and materials screening, the use of multi-welled assay plates has become standard for almost all automated experimental and storage applications.

Page 8: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

However many of these experimental procedures are compromised by positional inequalities between wells on outer and inner locations on the micro-plate.

These inequalities or “edge effects” become increasingly apparent as micro-plate densities increase.

Page 9: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

To improve reproducibility when conducting chemical and biological experiments, optimal environmental conditions must be maintained at all times.

To achieve this, it is often necessary to deploy costly and cumbersome environmental control systems. These systems dramatically reduce the experimental design flexibility of automated screening platforms and often do not solve the problem.

Page 10: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

Our solution

Page 11: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

Phase-lockTechnology

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

ThermalBuffering

Prevents evaporation

ImprovedCellGrowth

Betterwell to well consistency

Page 12: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

Plate

Gel

Side view and plan of gel plate showing construction of wells of plate surrounded by gel.

Wells

Page 13: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

Heat, CO2 passes into Gel down

thermal and concentration gradient

Loading in Incubator

Un-loading out of incubator

Page 14: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

A 384 well gel buffered bioreactor

Page 15: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

Top view of the 384 bioreactorplate with gel buffering

Page 16: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

Thermal buffering

Page 17: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1

1.1

0 5 10 15 20 25 30 35Time (mins)

tx/t

0 %

Cooling rate reduced

Thermal retention ~ 3 X Improved

SBS format plate

Comparison of cooling between normal and Biocroí plates

Page 18: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

Protection against evaporation

Page 19: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

Wells of 96 welled plates were filled with 100ul serum free culture medium and then maintained in a standard drying oven set at 50ºC for 48 hours. (Data expressed as percentage volume remaining after incubation time.

(See plate diagram to identify wells used in all experiments).

Page 20: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

Improved cell growth & reproducibility

Page 21: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

Wells of buffered and normal 96 well plates were seeded at (equally) low density with cells of immortalised cell line. Prior to maintenance in a standard tissue culture incubator (set at 37C, 95% air/ 5% CO2) for 48 hours. Both buffered and normal plates were placed in middle of incubator side by side.

Normal Plates Buffered Plates

Page 22: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

Non-insulated 96 well Insulated 96 well

DRASTIC REDUCTION OFEDGE EFFECTS

14710 (1871)

CV=12.7% 6.12%16805 (1029)

CV=

Page 23: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

The excellent environmental buffering properties of Biocroí plate technologies allows miniaturisation of cell based assays down to nanoliter volumes.

Page 24: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

High Content Image of cells reverse transfected with SiGlo in a gel buffered 192 nanoslide. (Volume 100nl)Miniaturised 1000XAs compared to 96-well plate assays normally performed at 100ul

Page 25: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

High Content Image of cells incubated in 100nl in a standard 384-well buffered plate

Page 26: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

Reproducibility of spotting 50 nanoliter siRNA in 384 buffered gel plate

Page 27: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

Dried 50 nanoliter siRNA spot overlain with 100 nanoliter lung carcinoma cells

Page 28: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

Advantages

Page 29: Biocroi web presentation 07 03-2012

Biocroí Ltd. Unit 3, 80 The Trinity CentreSt James’s Hospital, Dublin 8, Ireland

CONFIDENTIALITY NOTICEThis document is the property of Biocroí Ltd and contains confidential information. This document shall not be reproduced, copied, or used for any purposes without the express written permission of an authorized representative of the company.

Improved data quality

Substantial decrease in reagent & cell usage

Proven reduction in

edge effects

Increase in throughput productivity


Recommended